Does the Lectin Complement Pathway Link Kawasaki Disease and SARS-CoV-2?

Polycarpou, Anastasia; Grigoriadou, Sofia; Klavinskis, Linda; Sacks, Steven

Polycarpou, Anastasia; Grigoriadou, Sofia; Klavinskis, Linda; Sacks, Steven.

Polycarpou A; School of Immunology and Microbial Sciences, King's College London, London, United Kingdom.
Grigoriadou S; Immunology Department, Royal London Hospital, Barts Health NHS Trust, London, United Kingdom.
Klavinskis L; School of Immunology and Microbial Sciences, King's College London, London, United Kingdom.
Sacks S; School of Immunology and Microbial Sciences, King's College London, London, United Kingdom.

Front Immunol ; 11: 604512, 2020.

Article in English | MEDLINE | ID: covidwho-1389168

Subject(s)

COVID-19/complications; COVID-19/immunology; Complement Pathway, Mannose-Binding Lectin/immunology; Mucocutaneous Lymph Node Syndrome/immunology; Systemic Inflammatory Response Syndrome/immunology; Child; Child, Preschool; Female; Humans; Male; SARS-CoV-2

Keywords

COVID-19; Kawasaki disease; SARS-CoV-2; children; complement; lectin pathway; multisystem inflammatory syndrome; paediatric

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Systemic Inflammatory Response Syndrome / Complement Pathway, Mannose-Binding Lectin / COVID-19 / Mucocutaneous Lymph Node Syndrome Topics: Long Covid Limits: Child / Child, preschool / Female / Humans / Male Language: English Journal: Front Immunol Year: 2020 Document Type: Article Affiliation country: FIMMU.2020.604512

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google